SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...
WORTHINGTON, Ohio, October 14, 2025--(BUSINESS WIRE)--I Am Boundless, Inc., a nonprofit leader in integrated care for individuals with intellectual and developmental disabilities (I/DD) and behavioral ...
Targeted therapies and immunotherapies offer new treatment options for more types of cancer, but these drugs are less helpful when tumors produce multiple copies of a gene. This gene amplification ...
Boundless Bio's first direct ecDNA-targeting asset, is entering clinical trials with promising preclinical efficacy. Check out why BOLD stock is a buy.
Paulick Report on MSN
'Find Someone Who Says Yes': Sandy Hatfield Inspires On Boundless Podcast
The latest episode of jockey and veterinarian Dr. Ferrin Peterson’s “The Boundless Podcast” features an interview with Sandy ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Apr 22, 2021 at ...
Texas-based company Monumental announced it’s acquired Boundless, an MMO from developer Turbulenz. The development studio will partner with Turbulenz on future development of the open-world sandbox ...
Our education system is broken, from lower-level public schools all the way up to higher learning. EdTech startups are coming at the numerous problems from every angle. Boundless, a startup out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results